 abc13.com | SABCS: Updated BOLERO-2 Findings Confirm Efficacy of Everolimus Plus Exemestane Cancer Network SAN ANTONIO—Updated findings from the pivotal phase III Breast Cancer Trials of Oral Everolimus (BOLERO-2) study confirm dramatic improvement in progression-free survival (PFS) in women with metastatic breast ... Women With Previously Treated Advanced Breast Cancer Benefit From Addition Of ... Everolimus plus AI extends survival Study: Pill can help stop spread of cancer |
